Exploiting synthetic lethality is a promising strategy for developing targeted cancer therapies. However, identifying clinically significant synthetic lethal (SL) interactions among a large number of ...
A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform designed to “scan” the molecular features of each patient’s cancer. Published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results